v3.25.4
Pay vs Performance Disclosure - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Pay vs Performance Disclosure          
Pay vs Performance Disclosure, Table
Year(1)
Summary Compensation Table Total for CEO/PEO ($)
Compensation Actually Paid to CEO/PEO ($)(2)
Average Summary Compensation Table for Non-PEO Named Executive Officers ($)
Average Compensation Actually Paid to Non-PEO Named Executive Officers ($)(3)
Value of Initial Fixed $100
Investment Based On:
Net Income
($ millions)
Adjusted
Net Sales
($ millions)(5)
Total Shareholder Return ($)
Peer Group Total Shareholder Return ($)(4)
2025
23,532,050 
32,971,714 
5,837,482 
5,907,746 
265.23 
148.36 
2,892 
19,931 
2024
21,420,801 
65,818,468 
5,515,833 
15,177,435 
248.46 
129.46 
1,846 
16,741 
202318,723,735 38,596,387 4,865,206 9,121,400 160.81 126.21 
1,592 
14,257 
202216,941,961 21,632,710 4,884,001 5,984,751 128.71 123.67 
698 
13,206 
202116,064,039 20,440,299 3,905,481 4,972,710 118.16 126.13 
1,041 
11,646 
       
Company Selected Measure Name Adjusted Net Sales        
Named Executive Officers, Footnote The CEO/PEO and NEO/Non-PEO Named Executive Officers included in the above compensation columns reflect the following:
YearCEO/PEONon-PEO NEOs
2025
Michael F. Mahoney
Jonathan R. Monson, Vance R. Brown, Arthur C. Butcher, Joseph M. Fitzgerald, Daniel J. Brennan and Jeffrey B. Mirviss
2024
Michael F. Mahoney
Daniel J. Brennan, Arthur C. Butcher, Joseph M. Fitzgerald, and Jeffrey B. Mirviss
2023
Michael F. Mahoney
Daniel J. Brennan, Arthur C. Butcher, Joseph M. Fitzgerald, and Jeffrey B. Mirviss
2022
Michael F. Mahoney
Daniel J. Brennan, Arthur C. Butcher, Joseph M. Fitzgerald, and Jeffrey B. Mirviss
2021
Michael F. Mahoney
Daniel J. Brennan, Joseph M. Fitzgerald, Jeffrey B. Mirviss and David A. Pierce
       
Peer Group Issuers, Footnote We selected the Standard & Poor’s (S&P) 500 Health Care Index (referred to herein as the “Health Care Index”) as our peer group for purposes of this disclosure, which was comprised of 60-64 companies for the years 2021 through 2025 included in the S&P 500 that are classified as members of the GICS® Health Care sector primarily engaged in Health Care Equipment and Services, Pharmaceuticals, Biotechnology and Life Sciences, including the Company and other mid-cap and large-cap healthcare companies. The Health Care Index is the same performance peer group selected by the Compensation Committee for determining the achievement of targets of TSR performance-based RSUs granted to our NEOs, including our CEO, between 2021 and 2025. See Long Term Incentives on page 66 for additional information.        
PEO Total Compensation Amount $ 23,532,050 $ 21,420,801 $ 18,723,735 $ 16,941,961 $ 16,064,039
PEO Actually Paid Compensation Amount $ 32,971,714 65,818,468 38,596,387 21,632,710 20,440,299
Adjustment To PEO Compensation, Footnote "Compensation Actually Paid" to the CEO/PEO reflect the following adjustments from the amount reported in the “Total” compensation column of the Summary Compensation Table on page 76 of this Proxy Statement.
Adjustments to Determine Compensation “Actually Paid” for CEO/PEO
2025
($)
2024
($)
2023
($)
2022
($)
2021
($)
Total Reported in Summary Compensation Table
23,532,050 
21,420,801 
18,723,735 
16,941,961 
16,064,039 
Less Change in Actuarial Present Value reported under the “Change in Pension Value and Non-qualified Deferred Compensation Earnings” Column of the SCT
441,611 
291,666 
291,667 
376,667 
360,000 
Plus “Service Cost” for Pension Plans
— 
— 
— 
— 
— 
Less Amounts Reported under the “Stock Awards” Column of the SCT
13,608,056 
12,229,998 
10,472,753 
9,924,100 
9,126,292 
Less Amounts Reported under the “Option Awards” Column of the SCT
3,749,980 
3,562,493 
3,124,984 
2,874,985 
2,749,999 
Plus the Fair Value of Awards Granted during covered year that Remain Unvested as of Year-end
17,194,877 
30,707,960 
22,483,365 
13,748,034 
14,273,008 
Plus the Change in Fair Value from prior Year-end to current Year-end of Awards Granted prior to covered year that were Outstanding and Unvested as of Year-end
3,798,313 
26,602,863 
11,223,191 
4,283,677 
2,596,137 
Plus the Change in Fair Value from prior Year-end to Vesting Date of Awards Granted prior to covered year that Vested during covered year
6,246,121 
3,171,001 
55,500 
315,254 
903,733 
Less the Fair Value as of prior Year-End of Awards Granted prior to covered year that were Forfeited during covered year
— 
— 
— 
480,464 
1,160,327 
Total Adjustments
9,439,664 
44,397,667 
19,872,652 
4,690,749 
4,376,260 
Compensation Actually Paid
32,971,714 
65,818,468 
38,596,387 
21,632,710 
20,440,299 

*Compensation Actually Paid” does not correlate to the total amount of cash or equity compensation realized during each fiscal year and is different from “realizable” or “realized” compensation as reported in the Compensation Discussion & Analysis section of this Proxy Statement. Instead, it is a nuanced calculation that includes the increase or decrease in value of certain elements of compensation over each fiscal year, including compensation granted in a prior year, in accordance with Item 402(v) of Regulation S-K. The amount of compensation ultimately received may, in fact, be different from the amounts disclosed in these columns of the Pay Versus Performance Table.
       
Non-PEO NEO Average Total Compensation Amount $ 5,837,482 5,515,833 4,865,206 4,884,001 3,905,481
Non-PEO NEO Average Compensation Actually Paid Amount $ 5,907,746 15,177,435 9,121,400 5,984,751 4,972,710
Adjustment to Non-PEO NEO Compensation Footnote The average "Compensation Actually Paid" to the Non-PEO NEOs reflect the following adjustments from the amount reported in the “Total” compensation column of the Summary Compensation Table on page 76.
Adjustments to Determine Average Compensation “Actually Paid” for Non-PEO NEOs
2025 Average
($)
2024 Average
($)
2023 Average
($)
2022 Average
($)
2021 Average
($)
Total Reported in Summary Compensation Table
5,837,482 
5,515,833 
4,865,206 
4,884,001 
3,905,481 
Less Change in Actuarial Present Value reported under the “Change in Pension Value and Non-qualified Deferred Compensation Earnings” Column of the SCT
399,721 
145,042 
121,759 
122,326 
59,942 
Plus “Service Cost” for Pension Plans
6,153 
16,633 
15,308 
16,435 
— 
Less Amounts Reported under the “Stock Awards” Column of the SCT
2,757,988 
2,660,420 
2,324,937 
2,180,154 
1,918,553 
Less Amounts Reported under the “Option Awards” Column of the SCT
880,357 
774,991 
693,748 
693,740 
578,120 
Plus the Fair Value of Awards Granted during covered year that Remain Unvested as of Year-end
2,814,717 
6,680,034 
4,991,284 
3,103,987 
3,000,519 
Plus the Change in Fair Value from prior Year-end to current Year-end of Awards Granted prior to covered year that were Outstanding and Unvested as of Year-end
159,452 
5,867,592 
2,367,857 
1,004,348 
636,900 
Plus the Change in Fair Value from prior Year-end to Vesting Date of Awards Granted prior to covered year that Vested during covered year
1,128,008 
677,794 
22,189 
65,014 
208,010 
Less the Fair Value as of prior Year-End of Awards Granted prior to covered year that were Forfeited during covered year
— 
— 
— 
92,814 
221,585 
Total Adjustments
70,264 
9,661,602 
4,256,194 
1,100,750 
1,067,229 
Compensation Actually Paid
5,907,746 
15,177,435 
9,121,400 
5,984,751 
4,972,710 
“Compensation Actually Paid” does not correlate to the total amount of cash or equity compensation realized during each fiscal year and is different from “realizable” or “realized” compensation as reported in the Compensation Discussion & Analysis section of this Proxy Statement. Instead, it is a nuanced calculation that includes the increase or decrease in value of certain elements of compensation over each fiscal year, including compensation granted in a prior year, in accordance with Item 402(v) of Regulation S-K. The amount of compensation ultimately received may, in fact, be different from the amounts disclosed in these columns of the Pay Versus Performance Table.
       
Compensation Actually Paid vs. Total Shareholder Return
The graph below shows the relationship between (i) the five-year total return to stockholders on our common stock and the return on the Health Care Index, in each case assuming $100 was invested in our common stock and in the Health Care Index on December 31, 2020 and that any dividends were reinvested, and (ii) the CAP for our CEO/PEO and the average CAP for our non-PEO NEOs for each of 2021 through 2025.
Relationship Between Compensation Actually Paid and Company/Peer Group Total Shareholder Return
5600
       
Compensation Actually Paid vs. Net Income
The graph below shows the relationship between our net income and the CAP for our CEO/PEO and the average CAP for our non-PEO NEOs for each of 2021 through 2025.
Relationship Between Compensation Actually Paid and Net Income
5842
       
Compensation Actually Paid vs. Company Selected Measure
The graph below shows the relationship between our Adjusted Net Sales and the CAP for our CEO/PEO and the average CAP for our non-PEO NEOs for each of 2021 through 2025.
Relationship Between Compensation Actually Paid and Adjusted Net Sales
6108
       
Tabular List, Table
Adjusted Net Sales*
Adjusted EPS*
Adjusted OIM*
Organic Net Sales Growth*
Relative Total Shareholder Return
       
Total Shareholder Return Amount $ 265.23 248.46 160.81 128.71 118.16
Peer Group Total Shareholder Return Amount 148.36 129.46 126.21 123.67 126.13
Net Income (Loss) $ 2,892,000,000 $ 1,846,000,000 $ 1,592,000,000 $ 698,000,000 $ 1,041,000,000
Company Selected Measure Amount 19,931,000,000 16,741,000,000 14,257,000,000 13,206,000,000 11,646,000,000
PEO Name Michael F. Mahoney Michael F. Mahoney Michael F. Mahoney Michael F. Mahoney Michael F. Mahoney
Additional 402(v) Disclosure *    Adjusted Net Sales, Adjusted EPS, Adjusted OIM and Organic Net Sales Growth are non-GAAP financial measures. For a reconciliation of these non-GAAP financial measures to the most directly comparable GAAP financial measures and insight into how these non-GAAP financial measures are considered by management, please see Annex A to this Proxy Statement.        
Measure:: 1          
Pay vs Performance Disclosure          
Name Adjusted Net Sales*        
Non-GAAP Measure Description Adjusted Net Sales represents the most important financial performance measure (that is not otherwise required to be disclosed in the table) used by the Company to link CAP to our NEOs, including our CEO, for the most recently completed fiscal year to the Company’s performance. Adjusted Net Sales is a non-GAAP financial measure. For a reconciliation of Adjusted Net Sales to the most directly comparable GAAP financial measure and insight into how Adjusted Net Sales is considered by management, please see Annex A to this Proxy Statement.        
Measure:: 2          
Pay vs Performance Disclosure          
Name Adjusted EPS*        
Measure:: 3          
Pay vs Performance Disclosure          
Name Adjusted OIM*        
Measure:: 4          
Pay vs Performance Disclosure          
Name Organic Net Sales Growth*        
Measure:: 5          
Pay vs Performance Disclosure          
Name Relative Total Shareholder Return        
PEO          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount $ 9,439,664 $ 44,397,667 $ 19,872,652 $ 4,690,749 $ 4,376,260
PEO | Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (441,611) (291,666) (291,667) (376,667) (360,000)
PEO | Pension Adjustments Service Cost          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 0 0 0 0 0
PEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (13,608,056) (12,229,998) (10,472,753) (9,924,100) (9,126,292)
PEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 17,194,877 30,707,960 22,483,365 13,748,034 14,273,008
PEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 3,798,313 26,602,863 11,223,191 4,283,677 2,596,137
PEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 6,246,121 3,171,001 55,500 315,254 903,733
PEO | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 0 0 0 (480,464) (1,160,327)
PEO | Adjustment, Option Awards [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (3,749,980) (3,562,493) (3,124,984) (2,874,985) (2,749,999)
Non-PEO NEO          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 70,264 9,661,602 4,256,194 1,100,750 1,067,229
Non-PEO NEO | Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (399,721) (145,042) (121,759) (122,326) (59,942)
Non-PEO NEO | Pension Adjustments Service Cost          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 6,153 16,633 15,308 16,435 0
Non-PEO NEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (2,757,988) (2,660,420) (2,324,937) (2,180,154) (1,918,553)
Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 2,814,717 6,680,034 4,991,284 3,103,987 3,000,519
Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 159,452 5,867,592 2,367,857 1,004,348 636,900
Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 1,128,008 677,794 22,189 65,014 208,010
Non-PEO NEO | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 0 0 0 (92,814) (221,585)
Non-PEO NEO | Adjustment, Option Awards [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount $ (880,357) $ (774,991) $ (693,748) $ (693,740) $ (578,120)